SlideShare a Scribd company logo
1 of 10
Download to read offline
PRESENTATION
ON
Immunity against tumor
Name :AMMAR
MUHAMMAD
Chinese name : 高马尔
Student ID :
202219210902046
Major : Clinical Medicine
TOPIC :
How to recognize mutation
cells; How to eliminate tumor cells
TUMOR :
A tumor is an abnormal mass of tissue that can be
benign or malignant.Benign tumors are usually non-
cancerous and don't spread, while malignant tumors
are cancerous and can invade surrounding tissues.
Tumors can occur in various organs and tissues,and
their characteristics and effects depend on the type
and location
Immune monitoring :
The immune system plays a crucial role in
surveilling and combating tumors through
mechanisms like cytotoxicT cells recognizing
and destroying cancerous cells.
Immunotherapy aims to enhance this
immune response for more effective tumor
control.
RECOGNITION OF MUTATED CELLS:
Antigen Presentation:•
Antigen-presenting cells (APCs), like dendritic cells, ingest and process
tumor cells.They present fragments of these tumor-specific antigens on their surface, acting as
signals for the immune system. •
T CellActivation:•
CytotoxicT cells (CD8+ T cells) play a crucial role.When they encounter
APCs presenting tumor antigens, they become activated.This activation involves recognizing
the presented antigens through theirT cell receptors.
ELIMINATION OFTUMOR CELLS:
Natural killer cells:
Natural Killer cells, part of the innate immune system,
can recognize and directly kill abnormal cells, including tumor cells, without
prior sensitization. NK cells release perforin and granzymes as well,
contributing to tumor cell destruction.
CytotoxicT cells :
CytotoxicT cells recognize specific antigens on
the surface of tumor cells through theirT cell receptors (TCRs). Once
activated,they release cytotoxins like perforin and granzymes,inducing
apoptosis (cell death) in the tumor cells.
IMMUNOTHERAPIES:
Checkpoint inhibitors:
Checkpoint inhibitors are a type of immunotherapy that
targets proteins on immune cells and cancer cells, preventing the cancer cells from
evading immune attack. Examples include drugs like pembrolizumab and nivolumab.
These inhibitors "release the brakes" on the immune system,allowing it to recognize
and attack the cancer more effectively.
Antibodies:
Monoclonal antibodies are designed to target specific proteins
on the surface of cancer cells.They can either trigger the immune system to
attack the cancer directly or block signals that promote cancer growth.
CANCERVACCINES :
Cancer vaccines are a form of immunotherapy that aims
to stimulate the immune system to recognize and
destroy cancer cells.Unlike traditional vaccines that
prevent infectious diseases, cancer vaccines are designed
to treat existing cancer or prevent its recurrence.
They can be categorized as preventive vaccines,targeting
viruses associated with cancer,or therapeutic vaccines,
which stimulate the immune system to attack specific
cancer cells or antigens
Presentation Ammar final immunology apdf

More Related Content

Similar to Presentation Ammar final immunology apdf

Tumor immunology
Tumor immunologyTumor immunology
Tumor immunologyPashon Hana
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptxAnnie Annie
 
14.tumor immunology and immunotherapy
14.tumor  immunology and immunotherapy14.tumor  immunology and immunotherapy
14.tumor immunology and immunotherapySweta Shrestha
 
Tumour and transplant immunology.pptx seminar 4
Tumour and transplant immunology.pptx seminar 4Tumour and transplant immunology.pptx seminar 4
Tumour and transplant immunology.pptx seminar 4Dr. Mitali Thamke
 
Tumor immunology by nidhi
Tumor immunology by nidhiTumor immunology by nidhi
Tumor immunology by nidhiNidhiLilhare
 
Tumour immunology leture notes
Tumour immunology leture notesTumour immunology leture notes
Tumour immunology leture notesBruno Mmassy
 
MSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxMSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxLilianNkinda
 
Immunological aspects of cancer
Immunological aspects of cancerImmunological aspects of cancer
Immunological aspects of cancerPuppala Santosh
 
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...QIAGEN
 
Anti cancer treatments
Anti cancer treatmentsAnti cancer treatments
Anti cancer treatmentsMustafa Diaa
 
Cancer immunology.pptx
Cancer immunology.pptxCancer immunology.pptx
Cancer immunology.pptxAnnie Annie
 
Chapter 17 immunotherapy
Chapter 17 immunotherapyChapter 17 immunotherapy
Chapter 17 immunotherapyNilesh Kucha
 
Tumor Immunology presentation by Sharmista
Tumor Immunology presentation by SharmistaTumor Immunology presentation by Sharmista
Tumor Immunology presentation by SharmistaSharmistaChaitali
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsDr. Roopam Jain
 
Cancer immunotherapy nivedita shah msc.biotech- 13937
Cancer immunotherapy   nivedita shah  msc.biotech- 13937Cancer immunotherapy   nivedita shah  msc.biotech- 13937
Cancer immunotherapy nivedita shah msc.biotech- 13937eureka1
 

Similar to Presentation Ammar final immunology apdf (20)

Tumor immunology
Tumor immunologyTumor immunology
Tumor immunology
 
Cancer immunology
Cancer immunologyCancer immunology
Cancer immunology
 
tumor immunology.pptx
tumor immunology.pptxtumor immunology.pptx
tumor immunology.pptx
 
14.tumor immunology and immunotherapy
14.tumor  immunology and immunotherapy14.tumor  immunology and immunotherapy
14.tumor immunology and immunotherapy
 
Tumour and transplant immunology.pptx seminar 4
Tumour and transplant immunology.pptx seminar 4Tumour and transplant immunology.pptx seminar 4
Tumour and transplant immunology.pptx seminar 4
 
Tumor immunology by nidhi
Tumor immunology by nidhiTumor immunology by nidhi
Tumor immunology by nidhi
 
Tumour immunology leture notes
Tumour immunology leture notesTumour immunology leture notes
Tumour immunology leture notes
 
MSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptxMSI 825Tumor Immunology (1).pptx
MSI 825Tumor Immunology (1).pptx
 
Immunological aspects of cancer
Immunological aspects of cancerImmunological aspects of cancer
Immunological aspects of cancer
 
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
 
Anti cancer treatments
Anti cancer treatmentsAnti cancer treatments
Anti cancer treatments
 
Interaction of Radiation with Immunotherapy
Interaction of Radiation with ImmunotherapyInteraction of Radiation with Immunotherapy
Interaction of Radiation with Immunotherapy
 
Cancer immuno therapy
Cancer immuno therapyCancer immuno therapy
Cancer immuno therapy
 
Cancer immunology.pptx
Cancer immunology.pptxCancer immunology.pptx
Cancer immunology.pptx
 
Chapter 17 immunotherapy
Chapter 17 immunotherapyChapter 17 immunotherapy
Chapter 17 immunotherapy
 
Tumor Immunology presentation by Sharmista
Tumor Immunology presentation by SharmistaTumor Immunology presentation by Sharmista
Tumor Immunology presentation by Sharmista
 
640917.pptx
640917.pptx640917.pptx
640917.pptx
 
Tumor immunity
Tumor immunityTumor immunity
Tumor immunity
 
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of TumorsTUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
TUMOUR IMMUNOLOGY, CLINICAL ASPECTS OF NEOPLASIA & Clinical Features of Tumors
 
Cancer immunotherapy nivedita shah msc.biotech- 13937
Cancer immunotherapy   nivedita shah  msc.biotech- 13937Cancer immunotherapy   nivedita shah  msc.biotech- 13937
Cancer immunotherapy nivedita shah msc.biotech- 13937
 

Recently uploaded

How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 

Recently uploaded (20)

Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 

Presentation Ammar final immunology apdf

  • 2. Name :AMMAR MUHAMMAD Chinese name : 高马尔 Student ID : 202219210902046 Major : Clinical Medicine
  • 3. TOPIC : How to recognize mutation cells; How to eliminate tumor cells
  • 4. TUMOR : A tumor is an abnormal mass of tissue that can be benign or malignant.Benign tumors are usually non- cancerous and don't spread, while malignant tumors are cancerous and can invade surrounding tissues. Tumors can occur in various organs and tissues,and their characteristics and effects depend on the type and location
  • 5. Immune monitoring : The immune system plays a crucial role in surveilling and combating tumors through mechanisms like cytotoxicT cells recognizing and destroying cancerous cells. Immunotherapy aims to enhance this immune response for more effective tumor control.
  • 6. RECOGNITION OF MUTATED CELLS: Antigen Presentation:• Antigen-presenting cells (APCs), like dendritic cells, ingest and process tumor cells.They present fragments of these tumor-specific antigens on their surface, acting as signals for the immune system. • T CellActivation:• CytotoxicT cells (CD8+ T cells) play a crucial role.When they encounter APCs presenting tumor antigens, they become activated.This activation involves recognizing the presented antigens through theirT cell receptors.
  • 7. ELIMINATION OFTUMOR CELLS: Natural killer cells: Natural Killer cells, part of the innate immune system, can recognize and directly kill abnormal cells, including tumor cells, without prior sensitization. NK cells release perforin and granzymes as well, contributing to tumor cell destruction. CytotoxicT cells : CytotoxicT cells recognize specific antigens on the surface of tumor cells through theirT cell receptors (TCRs). Once activated,they release cytotoxins like perforin and granzymes,inducing apoptosis (cell death) in the tumor cells.
  • 8. IMMUNOTHERAPIES: Checkpoint inhibitors: Checkpoint inhibitors are a type of immunotherapy that targets proteins on immune cells and cancer cells, preventing the cancer cells from evading immune attack. Examples include drugs like pembrolizumab and nivolumab. These inhibitors "release the brakes" on the immune system,allowing it to recognize and attack the cancer more effectively. Antibodies: Monoclonal antibodies are designed to target specific proteins on the surface of cancer cells.They can either trigger the immune system to attack the cancer directly or block signals that promote cancer growth.
  • 9. CANCERVACCINES : Cancer vaccines are a form of immunotherapy that aims to stimulate the immune system to recognize and destroy cancer cells.Unlike traditional vaccines that prevent infectious diseases, cancer vaccines are designed to treat existing cancer or prevent its recurrence. They can be categorized as preventive vaccines,targeting viruses associated with cancer,or therapeutic vaccines, which stimulate the immune system to attack specific cancer cells or antigens